Table 1.
General characteristics of the patients and disease.
| Male | Female | ||
|---|---|---|---|
| Age (mean ± SD) | 62.13 ± 14.39 | 63.43 ± 13.75 | 57.00 ± 16.24 |
| Gender (n, %) | |||
| Male | 56 (79%) | ||
| Female | 15 (21%) | ||
| Anatomic area (%) | |||
| GEJ∗/proximal stomach | 38 (54%) | 29 (51%) | 10 (64%) |
| Distal stomach | 33 (46%) | 27 (49%) | 5 (36%) |
| Stage (%) | |||
| 3 | 28 (39%) | 21 (37%) | 6 (40%) |
| 4 | 43 (61%) | 35 (63%) | 9 (60%) |
| BMI# (mean ± SD) | 21.08 ± 3.99 | ||
| Metastasis | |||
| Metastatic | 43 (61%) | 21 (37%) | 6 (40%) |
| Nonmetastatic$ | 28 (39%) | 35 (63%) | 9 (60%) |
| SGA A | 13% | 15% | 9% |
| SGA B | 49% | 46% | 58% |
| SGA C | 38% | 39% | 33% |
| PG-SGA (mean ± SD) | 16.07 ± 5.02 | 15.76 ± 5.17 | 16.92 ± 4.70 |
∗Gastroesophageal junction.
∗∗Type of gastric adenocarcinoma.
#Body mass index.
$Unresectable gastric cancer.